AR085989A2 - Composiciones endoparasiticidas y proceso para su preparacion - Google Patents

Composiciones endoparasiticidas y proceso para su preparacion

Info

Publication number
AR085989A2
AR085989A2 ARP120101244A ARP120101244A AR085989A2 AR 085989 A2 AR085989 A2 AR 085989A2 AR P120101244 A ARP120101244 A AR P120101244A AR P120101244 A ARP120101244 A AR P120101244A AR 085989 A2 AR085989 A2 AR 085989A2
Authority
AR
Argentina
Prior art keywords
composition according
preparation
cyclodepsipeptide
morpholinyl
compositions
Prior art date
Application number
ARP120101244A
Other languages
English (en)
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of AR085989A2 publication Critical patent/AR085989A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones endoparasiticidas, aplicables de manera tópica, que contienen depsipéptidos cíclicos y de cadena abierta, constituidos por aminoácidos y ácidos hidroxicarboxílicos como componentes y que contienen de 6 hasta 30 átomos en el anillo o en la cadena, a su preparación y a su empleo como endoparasiticidas.Reivindicación 1: Composición adecuada para la administración tópica en animales caracterizada porque que comprende un ciclodepsipeptido de la fórmula (1), donde Z representa N-morfolinilo, amino, mono- o dimetilamino, solo o en combinación con otros compuestos activos, y 1,2-isopropiliden glicerina. Reivindicación 2: Composición de acuerdo con la reivindicación 1, caracterizada porque comprende el ciclodepsipeptido donde ambos radicales Z representan N-morfolinilo. Reivindicación 3: Composición de acuerdo con la reivindicación 1 ó 2, caracterizada porque adicionalmente comprende alcohol bencilico y/o propilen glicol diacetato. Reivindicación 5: Composición de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque comprende Praziquantel como compuesto activo adicional.
ARP120101244A 2000-02-22 2012-04-11 Composiciones endoparasiticidas y proceso para su preparacion AR085989A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel

Publications (1)

Publication Number Publication Date
AR085989A2 true AR085989A2 (es) 2013-11-13

Family

ID=7631886

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010100751A AR028218A1 (es) 2000-02-22 2001-02-20 Composicion endoparasiticidas
ARP120101244A AR085989A2 (es) 2000-02-22 2012-04-11 Composiciones endoparasiticidas y proceso para su preparacion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP010100751A AR028218A1 (es) 2000-02-22 2001-02-20 Composicion endoparasiticidas

Country Status (25)

Country Link
US (1) US20030125244A1 (es)
EP (1) EP1259250B1 (es)
JP (2) JP5596249B2 (es)
KR (1) KR100755414B1 (es)
CN (1) CN1309415C (es)
AR (2) AR028218A1 (es)
AT (1) ATE343394T1 (es)
AU (2) AU4060501A (es)
BR (1) BR0108562B1 (es)
CA (1) CA2400610C (es)
CZ (1) CZ300242B6 (es)
DE (2) DE10008128A1 (es)
DK (1) DK1259250T3 (es)
ES (1) ES2274871T3 (es)
HK (1) HK1054326B (es)
HU (1) HUP0204554A3 (es)
IL (2) IL150988A0 (es)
MX (1) MXPA02008210A (es)
NO (1) NO328949B1 (es)
NZ (1) NZ520856A (es)
PL (1) PL203999B1 (es)
PT (1) PT1259250E (es)
RU (1) RU2292905C2 (es)
WO (1) WO2001062268A1 (es)
ZA (1) ZA200205982B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
CA2504309A1 (en) * 2002-11-12 2004-05-27 The Kitasato Institute Novel substance fki-1033 and process for producing the same
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
AU2009286380B2 (en) 2008-08-28 2011-09-15 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
NZ737610A (en) 2015-05-20 2023-07-28 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds
US10344056B2 (en) 2015-12-28 2019-07-09 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
MX2019005628A (es) 2016-11-16 2019-12-18 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidos antihelminticos.
AU2020328863A1 (en) 2019-08-14 2022-04-07 Vetoquinol Sa Compositions comprising tigolaner for controlling parasites

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
AU669883B2 (en) * 1992-03-17 1996-06-27 Astellas Pharma Inc. Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (fr) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha Preparation sous forme de solution a base d'une forte concentration d'aureobasidine
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
EP1063992B1 (en) * 1998-03-19 2005-05-11 Merck & Co., Inc. Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
PL203999B1 (pl) 2009-11-30
KR100755414B1 (ko) 2007-09-04
CZ20022867A3 (cs) 2003-01-15
HUP0204554A2 (en) 2003-05-28
RU2292905C2 (ru) 2007-02-10
AR028218A1 (es) 2003-04-30
NZ520856A (en) 2005-04-29
IL150988A0 (en) 2003-02-12
ATE343394T1 (de) 2006-11-15
AU2001240605B2 (en) 2005-04-21
DE10008128A1 (de) 2001-08-23
US20030125244A1 (en) 2003-07-03
CZ300242B6 (cs) 2009-03-25
BR0108562A (pt) 2002-11-12
CN1309415C (zh) 2007-04-11
CA2400610C (en) 2013-01-22
EP1259250A1 (de) 2002-11-27
MXPA02008210A (es) 2003-01-28
DE50111315D1 (de) 2006-12-07
NO20023976D0 (no) 2002-08-21
NO328949B1 (no) 2010-06-28
HK1054326B (zh) 2007-11-09
EP1259250B1 (de) 2006-10-25
KR20020072577A (ko) 2002-09-16
CA2400610A1 (en) 2001-08-30
CN1404397A (zh) 2003-03-19
IL150988A (en) 2011-06-30
PT1259250E (pt) 2007-01-31
HK1054326A1 (en) 2003-11-28
ES2274871T3 (es) 2007-06-01
HUP0204554A3 (en) 2005-05-30
BR0108562B1 (pt) 2013-03-05
PL357551A1 (en) 2004-07-26
RU2002125493A (ru) 2004-03-20
NO20023976L (no) 2002-10-21
JP2003523397A (ja) 2003-08-05
JP5596249B2 (ja) 2014-09-24
AU4060501A (en) 2001-09-03
DK1259250T3 (da) 2007-02-26
JP2012107024A (ja) 2012-06-07
WO2001062268A1 (de) 2001-08-30
ZA200205982B (en) 2003-07-28

Similar Documents

Publication Publication Date Title
AR085989A2 (es) Composiciones endoparasiticidas y proceso para su preparacion
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
AR030312A1 (es) Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
ES2122520T3 (es) Composicion de limpieza con dos partes que comprende al menos un compuesto de peroxido.
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
GT199900203A (es) Composiciones de celecoxib.
UY27388A1 (es) Nuevos compuestos
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
ECSP077348A (es) Composiciones de amitraz
CR6654A (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
EA200702593A1 (ru) Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами
BRPI0413957A (pt) processo para preparar diterpenos solúveis em água, solução aquosa e suas aplicações
UY28366A1 (es) Compuestos químicos
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
UY27727A1 (es) Nueva composicion farmacéutica-
BRPI0511387A (pt) composição e seu uso
BR0215303A (pt) Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol
PE20010359A1 (es) Formulaciones ectoparasiticidas organicas topicas
UY28622A1 (es) Agentes antibacterianos de quinolona
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral

Legal Events

Date Code Title Description
FB Suspension of granting procedure